Palmitoyl Tripeptide-1 vs SNAP-25 Fragment
A side-by-side research comparison of Palmitoyl Tripeptide-1 and SNAP-25 Fragment across mechanism, dosing, half-life, benefits, side effects and research status.
Comparison table
| Attribute | Palmitoyl Tripeptide-1 | SNAP-25 Fragment |
|---|---|---|
| Full name | Palmitoyl Tripeptide-1 (Pal-GHK) | SNAP-25 Inhibitory Fragment Peptide |
| Category | Skin & Anti-Aging | Skin & Anti-Aging |
| Status | Research compound | Research compound |
| Mechanism | Functions as matrikine signal, mimicking collagen fragments that trigger fibroblasts to produce new collagen. Palmitoyl enables deeper skin penetration. | Directly competes with the SNAP-25 binding domain in SNARE complex formation, providing highly specific inhibition of vesicle fusion at facial neuromuscular junctions. |
| Molecular weight | 578.8 Da | ~650 Da |
| Half-life | 8-12 hours (topical) | N/A (topical depot) |
| Bioavailability | Good (topical with lipid modification) | Topical penetration ~6-9% |
| Typical dose | 2-5% in formulation | 3-8% in formulation |
| Frequency | 1-2x daily | 2x daily |
| Route | Topical | Topical serum |
Palmitoyl Tripeptide-1 reported benefits
- Collagen synthesis stimulation
- Matrix remodeling
- Wrinkle reduction
- Skin thickness increase
SNAP-25 Fragment reported benefits
- Highly specific SNARE targeting
- Expression line reduction
- Improved selectivity
- Complementary to Argireline
Related comparisons
Research and educational reference only. Not medical advice.